ALLR Stock Analysis: Buy, Sell, or Hold?
ALLR - Allarity Therapeutics, Inc. Common Stock
$1.43
0.00 (-0.01%)
▼
5d:
+4.36%
30d:
+17.2%
90d:
-13.87%
WAIT
LOW Confidence
Analysis Updated: Aug 20, 2026 12:00 AM ET
Earnings: Aug 21, 2026
0d
Get Alerted When ALLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALLR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALLR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALLR is currently trading at $1.43, which is considered extended relative to its 30-day fair value range of $1.19 to $1.39.
Technical Outlook: Technically, ALLR is in a uptrend. Immediate support is located at $1.25, while resistance sits at $1.55.
Market Sentiment: ALLR scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.25 (+616.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALLR is in a uptrend. Immediate support is located at $1.25, while resistance sits at $1.55.
Market Sentiment: ALLR scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.25 (+616.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.19 -
$1.39
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 616.8% below Wall St target ($10.25)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.19 -
$1.39
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.25
Resistance Level
$1.55
Current Trend
Uptrend
Technical data as of
Aug 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.47
Wall Street Target
$10.25
(+616.8%)
Share & Embed Analysis
Last updated: August 21, 2026 11:12 AM ET
Data refreshes hourly during market hours. Next update: 12:12 PM
Data refreshes hourly during market hours. Next update: 12:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 45 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1100 | 37 SELL |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$121 | 41 HOLD |
